|
End-of-day quote
Shanghai S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 68.78 CNY | +5.06% |
|
-5.24% | +1.04% |
| 04:46am | Gan & Lee Pharma's H1 Profit Rises 1%, Revenue Climbs 8% | MT |
| 08-25 | Gan & Lee Pharmaceuticals Subsidiary Secures China Clinical Trial Nod for Weight Loss Drug | MT |
| Market Cap | 40.94B 6.09B 5.22B 4.89B 4.47B 8.43B 581B 8.51B 57.69B 22.46B 293B 22.87B 22.37B 970B | P/E 2026 * |
29.6x | P/E 2027 * | 25.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.73B 5.61B 4.81B 4.51B 4.12B 7.77B 535B 7.85B 53.16B 20.7B 270B 21.08B 20.62B 894B | EV / Sales 2026 * |
7.98x | EV / Sales 2027 * | 6.61x |
| Free-Float |
57.83% | Yield 2026 * |
0.35% | Yield 2027 * | 0.41% |
| 1 day | +5.06% | ||
| 1 week | -5.24% | ||
| Current month | +0.07% | ||
| 1 month | +8.66% | ||
| 3 months | +28.44% | ||
| 6 months | +2.63% | ||
| Current year | +1.04% |
| 1 week | 65 |  | 74.6 |
| 1 month | 62.9 | | 79.99 |
| Current year | 51.51 | | 79.99 |
| 1 year | 51.51 | | 82.25 |
| 3 years | 32.1 | | 82.25 |
| 5 years | 30.53 | | 83.38 |
| 10 years | 30.53 | | 204.41 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Chen
CEO | Chief Executive Officer | 46 | 2025-05-29 |
Qi Wang
DFI | Director of Finance/CFO | 44 | 2026-03-08 |
Ting Jia
CTO | Chief Tech/Sci/R&D Officer | - | 2026-03-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhong Ru Gan
CHM | Chairman | 78 | 1998-06-16 |
Kai Du
BRD | Director/Board Member | 49 | 2009-12-31 |
Wei Qiang Song
BRD | Director/Board Member | 44 | 2015-09-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.06% | -5.24% | -3.87% | +62.41% | 6.09B | |
| +0.61% | +2.88% | +45.63% | +0.39% | 83.24B | |
| -0.69% | +3.58% | -19.85% | -35.64% | 59.49B | |
| +14.36% | +152.27% | +526.55% | +41.90% | 63.41B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 52.94B | |
| -1.78% | +1.06% | +10.19% | +167.83% | 49.86B | |
| +1.21% | +3.87% | +61.90% | -16.51% | 32.62B | |
| +1.36% | +5.06% | +53.04% | +103.13% | 26.29B | |
| +9.69% | +11.76% | +14.67% | +215.97% | 22.23B | |
| -0.83% | +0.09% | +60.91% | +122.54% | 17.22B | |
| Average | +1.31% | +18.11% | +74.93% | +69.82% | 41.34B | |
| Weighted average by Cap. | +0.30% | +26.91% | +99.87% | +49.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.73B 703M 603M 565M 516M 973M 67.04B 983M 6.66B 2.59B 33.82B 2.64B 2.58B 112B | 5.53B 823M 705M 661M 604M 1.14B 78.47B 1.15B 7.8B 3.03B 39.59B 3.09B 3.02B 131B |
| Net income | 1.39B 207M 177M 166M 152M 287M 19.75B 290M 1.96B 764M 9.96B 778M 761M 32.99B | 1.63B 242M 207M 194M 178M 335M 23.08B 338M 2.29B 893M 11.65B 909M 889M 38.57B |
| Net Debt | -3.21B -478M -409M -384M -350M -661M -45.54B -668M -4.52B -1.76B -22.97B -1.79B -1.75B -76.08B | -4.36B -649M -556M -521M -476M -898M -61.86B -907M -6.15B -2.39B -31.21B -2.44B -2.38B -103B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | CN¥68.78 | +5.06% | 12,908,972 |
| 26-08-24 | CN¥65.47 | -4.33% | 10,725,855 |
| 26-08-21 | CN¥68.43 | -4.79% | 16,008,003 |
| 26-08-20 | CN¥71.87 | +0.94% | 18,887,443 |
| 26-08-19 | CN¥71.20 | -1.90% | 11,984,320 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 603087 Stock
Select your edition
All financial news and data tailored to specific country editions
